Submit your Defective Drugs claim details for a free, no obligation case review.
Get Started:
drug_recall celebrexCelebrex class action lawsuits are being filed in the United States and in other countries against the manufacturers of this potentially dangerous prescription pain reliever. Celebrex class action lawsuits that have been filed are charging Pfizer with negligently marketing a prescription drug despite the fact that it has the potential to cause serious side effects in Celebrex users. A Celebrex class action lawsuit was filed in Illinois in late December 2004 charging Pfizer with failing to adequately inform patients of the serious risks associated with Celebrex use. This is believed to be the first Celebrex class action lawsuit to be filed in the United States.
This Celebrex class action lawsuit has been filed on behalf of patients who have taken Celebrex but have not suffered any serious injury as a result. Through this Celebrex class action lawsuit, the plaintiffs are seeking money for periodic health examinations that would enable early prevention, detection, and treatment of any injury or disease that may be linked to Celebrex use.
A recent 1.2 billion dollar Celebrex class action lawsuit in Canada was filed against Pfizer for their injurious marketing strategies of Celebrex in this nation. Legal experts in the United States predict that a number of Celebrex class action lawsuits will be filed in the near future, in light of recent clinical trial data.
In December 2004, Pfizer announced that a recent clinical trial revealed that patients taking Celebrex were at an increased risk of suffering serious cardiovascular injury. The National Cancer Institute had begun a clinical trial to test the efficiency of Celebrex in preventing some forms of cancer. Preliminary evidence from this study suggests that people who are taking between 400 and 800 milligrams of Celebrex are up to three times more likely to suffer heart attack or stroke than those patients who do not take Celebrex.
Pfizer announced that they plan to conduct further investigation of these findings but have stated that they have no plans to pull Celebrex off the market. Celebrex class action lawsuits warrant that, in light of this research, Pfizer is putting patients at an unnecessary risk by allowing Celebrex to remain on the market.
This Celebrex safety information was revealed just two months after another similar drug was pulled off the shelves. Vioxx was voluntarily recalled after studies found that this pain medication doubled a person''s chance of suffering heart attack or stroke. The makers of Vioxx are also facing a number of class action lawsuits in response to these dangers.
The results of recent Celebrex clinical trial data are not the first to link Celebrex with cardiovascular risks. This suggests that Pfizer potentially new about these Celebrex side effect risks but chose to continue to market an unsafe product. This is the foundation of many present Celebrex class action lawsuits and those to come. If you are interested in learning more about your legal rights and options in a Celebrex class action lawsuit, you may wish to contact a qualified and experienced legal professional.
After COX-2 painkillers – Vioxx, Celebrex and Bextra- came under scrutiny when cardiovascular risks were associated to the drugs some drugmakers saw this as an opportunity to try to capitalize on the events.
Vioxx went off the market in Se...
Merck & Co. and Pfizer Inc. have been criticized for their aggressive marketing campaigns for its COX-2 drugs, putting scrutiny on pharmaceutical advertising as a whole. Between December 2003 and November 2004, pharmaceutical ad spending increased 30...
A three-day FDA Advisory Committee meeting has wrapped, but the COX-2 drugs controversy is still not resolved. Although the panel of government medical experts advised keeping the drugs, including Pfizer Inc.’s Celebrex and Bextra, on the market, new...